Free tool
FAERS Monitor: Furosemide
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018823 or its brand name (Furosemide, Furosemide). Reports on generic versions are filed under their own applications.
Reports
265,537
Serious
219,231
83% of reports
Hospitalization
129,766
Death reported
40,876
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea18,437
- acute kidney injury16,467
- fatigue13,248
- diarrhoea13,195
- death12,368
- nausea11,534
- fall11,003
- off label use10,842
- drug ineffective10,424
- hypotension10,330
- pneumonia10,172
- dizziness9,887
- asthenia9,287
- headache8,706
- pain8,196
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,479 |
| 2005 | 3,857 |
| 2006 | 3,623 |
| 2007 | 3,214 |
| 2008 | 3,608 |
| 2009 | 3,997 |
| 2010 | 4,832 |
| 2011 | 6,479 |
| 2012 | 7,274 |
| 2013 | 7,405 |
| 2014 | 10,059 |
| 2015 | 13,254 |
| 2016 | 16,201 |
| 2017 | 16,716 |
| 2018 | 21,192 |
| 2019 | 23,004 |
| 2020 | 20,355 |
| 2021 | 18,734 |
| 2022 | 16,306 |
| 2023 | 16,473 |
| 2024 | 17,411 |
| 2025 | 16,227 |
| 2026 | 11,830 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,788,622 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 16,467 | 9.4 | 9.3 | 111,550 |
| hypotensionSignal | 10,330 | 4.2 | 4.2 | 24,547 |
| fallSignal | 11,003 | 2.7 | 2.6 | 11,327 |
| dyspnoeaSignal | 18,437 | 2.6 | 2.6 | 18,561 |
| pneumoniaSignal | 10,172 | 2.5 | 2.5 | 9,315 |
| asthenia | 9,287 | 2.0 | 1.9 | 4,477 |
| diarrhoea | 13,195 | 1.6 | 1.6 | 3,263 |
| dizziness | 9,887 | 1.6 | 1.6 | 2,123 |
| fatigue | 13,248 | 1.4 | 1.3 | 1,250 |
| nausea | 11,534 | 1.2 | 1.1 | 250 |
| death | 12,368 | 1.1 | 1.1 | 216 |
| headache | 8,706 | 1.1 | 1.1 | 82 |
| pain | 8,196 | 1.1 | 1.0 | 26 |
| off label use | 10,842 | 1.0 | 1.0 | 4 |
| drug ineffective | 10,424 | 0.6 | 0.6 | 2,508 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.